Table 5.
Comparison of the occurrence of adverse reactions in the two groups (cases (%)).
| Group | Number of cases | Gastrointestinal irritation | Mental symptoms | Joint edema | Total incidence (%) |
|---|---|---|---|---|---|
| Triamcinolone acetonide formation | 42 | 2 (4.76) | 4 (9.52) | 4 (9.52) | 23.81 |
| Sodium hyaluronate group | 42 | 1(2.38) | 1 (2.38) | 1 (2.38) | 7.14 |
Comparison with the total incidence in the tretinoin group, ap < 0.05.